Evidence map›Paper›PMID 39446892›Full record

ArticlePLOS global public health2024

Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working Group.

Robin Schaefer, Logan Donaldson, Mitchell Leus, Chukwunomso E Osakwe, Benjamin Chimukangara, Shona Dalal, Ann Duerr, Fei Gao, David V Glidden, Beatriz Grinsztejn and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Robin SchaeferForum for Collaborative Research, University of California, Berkeley, Washington, District of Columbia, United States of America.ORCID https://orcid.org/0000-0003-4733-4692
Logan DonaldsonForum for Collaborative Research, University of California, Berkeley, Washington, District of Columbia, United States of America.
Mitchell LeusForum for Collaborative Research, University of California, Berkeley, Washington, District of Columbia, United States of America.
Chukwunomso E OsakweForum for Collaborative Research, University of California, Berkeley, Washington, District of Columbia, United States of America.ORCID https://orcid.org/0009-0004-7251-2846
Benjamin ChimukangaraNational Institutes of Health, Bethesda, Maryland, United States of America.
Shona DalalGlobal HIV, Hepatitis, and STIs Programmes, World Health Organization, Geneva, Switzerland.
Ann DuerrFred Hutchinson Cancer Center, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-3399-2208
Fei GaoFred Hutchinson Cancer Center, Seattle, Washington, United States of America.
David V GliddenUniversity of California, San Francisco, California, United States of America.
Beatriz GrinsztejnInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil.
Jessica JustmanICAP at Columbia University, Mailman School of Public Health, New York, New York, United States of America.
Grace KumwendaAVAC, Southern Region, Malawi.
Oliver LaeyendeckerNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.ORCID https://orcid.org/0000-0002-6429-4760
Ha Youn LeeKeck School of Medicine, University of Southern California, Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0001-7260-2383
Frank MaldarelliNational Cancer Institute, Bethesda, Maryland, United States of America.
Kenneth H MayerThe Fenway Institute, Fenway Health, Boston, Massachusetts, United States of America.
Jeffrey MurrayIndependent consultant, Lewes, Delaware, United States of America.
Bharat S ParekhDivision of Global HIV & TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0002-1088-4263
Brian RiceThe University of Sheffield, Sheffield, United Kingdom.ORCID https://orcid.org/0000-0002-5416-8058
Michael N RobertsonBDI Consulting, Nipomo, California, United States of America.ORCID https://orcid.org/0009-0001-0022-4755
Suzue SaitoICAP at Columbia University, Mailman School of Public Health, New York, New York, United States of America.ORCID https://orcid.org/0000-0001-9725-5736
Vani VannappagariViiV Healthcare, Durham, North Carolina, United States of America.
Mitchell WarrenAVAC, New York, New York, United States of America.ORCID https://orcid.org/0000-0003-3626-7156
Diana ZeballosInstituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Bahia, Brazil.ORCID https://orcid.org/0000-0003-2045-765X
Jörg ZinserlingBundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany.
Veronica MillerForum for Collaborative Research, University of California, Berkeley, Washington, District of Columbia, United States of America.

Funding

HIV Incidence Assay via Deep Sequencing and Statistical TestsR01AI095066 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LEE, HA YOUN · 2011 to 2025
$8.4M
NIAID NIH HHS R01 AI095066World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39446892
PMCPMC11501012

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.